Docsa, Tibor <br/><br/>
Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats.  [electronic resource] 

 -  Current topics in medicinal chemistry  2015 
 - 2390-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-4294 
<br/><br/><label>Standard No.: </label>10.2174/1568026615666150622091407  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Glucose--analysis<br/>Diabetes Mellitus, Experimental--blood<br/>Glycogen--metabolism<br/>Glycogen Phosphorylase--antagonists & inhibitors<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--administration & dosage<br/>Insulin Resistance<br/>Liver--drug effects<br/>Male<br/>Monosaccharides--administration & dosage<br/>Rats, Wistar<br/>Spiro Compounds--administration & dosage<br/>Streptozocin